glp 1 coverage 2025 The future of GLP-1s: Cost, access and more trends HR must know kff employer health benefits survey

While this is a very dated way of looking at health, medically, a BMI of 30 or higher or a BMI of 27 or higher with at least one weight-related comorbidity (such as type 2 diabetes, high blood pressure or high cholesterol) makes you a candidate

PLOS Glob Public Health

Switching to retatrutide Moving from a dual agonist (tirzepatide) to a triple agonist (retatrutide) is generally smoother because retatrutide maintains GLP-1 and GIP activation while adding glucagon receptor stimulation

Many patients can continue treatment with dose adjustments, dietary modifications, or supportive medications to manage symptoms

They get most of their calories from fat and protein

p = 0.02) and waist circumference (4.78 cm vs